Dr. Rachel Kleinerman Gober, MD

Dr. Gober practices at University of Miami Hospital in Miami, Florida.

Dr. Gober's NPI, 1083034581, was assigned on April 23, 2014. Dr. Gober holds Florida license ME131821.

Dr. Gober's primary practice is University of Miami Hospital, at 1400 Nw 12th Ave, Miami, FL 33136 in Miami-Dade County. The practice phone is (305) 325-5511.

Dr. Gober's primary practice is University of Miami Hospital in Miami, Florida. Dr. Gober is also affiliated with Sylvester Comprehensive Cancer Center. The medical group on file is Paragon Contracting Services. Dmand AI also links Dr. Gober to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gober practices, 3 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Gober's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. Gober is licensed in Florida.

CMS data shows 340 Medicare services from Dr. Gober across 4 procedure codes in 2024, for 323 Medicare patients. Medicare paid $47,602 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 323 Medicare patients who saw Dr. Gober in 2024. The largest group is 65 to 74, with 105 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 56% are also on Medicaid. Their average risk score is 3.10, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gober's median patient age at 62, with 56% women.

In 2024, Dr. Gober wrote 281 Medicare Part D claims for 202 patients. 92% of them were for generic drugs. CMS names the drug for 126 of them, across 7 drugs with 11 or more claims each, at $1,050 in total drug cost. In 2023, CMS named 80 claims across 5 drugs.

Dr. Gober accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 2 general payments to Dr. Gober from 2 drug and device companies from 2021 to 2024. Food and beverage make up the largest share, 100% of the total. Alexion Pharmaceuticals, Inc. paid the most, $35.